SciBase Announces the Launch of EBarrier Score, the First AI-Driven Skin Barrier Assessment Tool for Research and Cosmetic Testing
SciBase Announces the Launch of EBarrier Score, the First AI-Driven Skin Barrier Assessment Tool for Research and Cosmetic Testing
STOCKHOLM, May 29, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of artificial intelligence (AI)-based solutions for skin disorders is pleased to announce the launch of the eBarrier Score for Nevisense, the first-ever AI skin barrier assessment tool built for use in research and cosmetic testing. The eBarrier Score was announced today at the Cosmetotest cosmetic testing symposium in Lyon, France.
斯德哥爾摩，2024 年 5 月 29 日 /PRNewswire/-- SciBase Holding AB（“SciBase”） （停止：SCIB），基於人工智能 (AI) 的皮膚病解決方案的領先開發商 很高興地宣佈推出適用於Nevisense的eBarrier Score，這是有史以來第一個用於研究和美容測試的人工智能皮膚屏障評估工具。eBarrier評分今天在法國里昂舉行的Cosmetotest化妝品測試研討會上公佈。
Researchers of the skin barrier and cosmetic products can now use Nevisense and the eBarrier Score to assess products and claims related to skin barrier function. The global market for cosmetic products aiming to improve people's skin barrier is experiencing immense growth.
皮膚屏障和化妝品的研究人員現在可以使用Nevisense和eBarrier Score來評估與皮膚屏障功能相關的產品和聲明。旨在改善人們皮膚屏障的化妝品的全球市場正在經歷巨大的增長。
Nevisense and the eBarrier Score utilize AI-generated algorithms that researchers can use to directly quantitate the severity of skin barrier dysfunction related to common skin disorders.
Nevisense和eBarrier Score利用人工智能生成的算法，研究人員可以使用這些算法直接量化與常見皮膚疾病相關的皮膚屏障功能障礙的嚴重程度。
In a recently published study (Skin Barrier Function Assessment: Electrical Impedance Spectroscopy Is Less Influenced by Daily Routine Activities Than Transepidermal Water Loss - the first direct comparison between electrical impedance spectroscopy (EIS) using Nevisense and trans-epidermal water loss (TEWL) was made. The study demonstrates Nevisense being a more robust technique to assess skin barrier function than the within research commonly used TEWL measurement technique.
在最近發表的一項研究（皮膚屏障功能評估：電阻抗譜學受日常活動的影響小於經皮水分流失）中，首次對使用Nevisense的電阻抗譜（EIS）和經表皮水分流失（TEWL）進行了直接比較。該研究表明，與內部研究中常用的TEWL測量技術相比，Nevisense是評估皮膚屏障功能的更可靠的技術。
"We are thrilled to introduce the eBarrier Score to the cosmetic research market," said Pia Renaudin, CEO of SciBase. "Every day, there are new cosmetic products related to skin barrier function. The Nevisense eBarrier Score is already an established tool in the medical research field and bringing it to the cosmetic research market will truly benefit consumers."
SciBase首席執行官皮亞·雷諾丁說：“我們很高興將eBarrier Score引入化妝品研究市場。”“每天都有與皮膚屏障功能有關的新化妝品。Nevisense eBarrier Score已經是醫學研究領域的既定工具，將其引入化妝品研究市場將真正使消費者受益。”
For more information on the eBarrier Score and SciBase's other research or medical products, visit scibase.com. In February SciBase announced a partnership with Skinobs, a leading global platform connecting researchers with the tools they need for their cosmetic and medical research. Through this partnership, SciBase can now offer Nevisense and eBarrier for assessing skin barrier function within cosmetic testing on the Skinobs platform.
有關eBarrier Score和SciBase其他研究或醫療產品的更多信息，請訪問scibase.com。2月，SciBase宣佈與Skinobs建立合作伙伴關係，Skinobs是一個領先的全球平台，爲研究人員提供化妝品和醫學研究所需的工具。通過這種合作關係，SciBase現在可以提供Nevisense和eBarrier，用於評估Skinobs平台美容測試中的皮膚屏障功能。
For additional information, please contact:
Pia Renaudin, VD, tel. +46732069802, e-mail: [email protected]
Certified Advisor (CA):
Vator Securities
Tel: +46 8 580 065 99
Email: [email protected]
欲了解更多信息，請聯繫：
Pia Renaudin，VD，電話 +46732069802，電子郵件：[email protected]
認證顧問 (CA)：
Vator 證券
電話：+46 8 580 065 99
電子郵件：[電子郵件保護]
About SciBase:
關於 SciBase：
SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.
SciBase 是一家全球醫療技術公司，專門從事皮膚病學的早期發現和預防。SciBase 開發並商業化了 Nevisense，這是一個獨特的即時護理平台，它結合了人工智能（人工智能）和先進的 EIS 技術，可提高診斷準確性，確保積極的皮膚健康管理。
Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.
我們的承諾是最大限度地減少患者的痛苦，使臨床醫生能夠通過及時的檢測和干預來改善和挽救生命，並降低醫療成本。
Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.
SciBase建立在瑞典斯德哥爾摩卡羅林斯卡研究所20多年的研究基礎上，是皮膚病學進步領域的領導者。
The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015. Learn more at . All press releases and financial reports can be found here:
該公司自2015年6月2日起在納斯達克第一北方成長市場交易所上市。要了解更多，請訪問。所有新聞稿和財務報告都可以在這裏找到：
This information was brought to you by Cision
這些信息是由 Cision 帶給你的
The following files are available for download:
以下文件可供下載：
|
eBarrier Score PR |
|
eBarrier 評分公關 |